Nutrition Business Journal

Cevena Bioproducts Bulks Up Business With Beta-Glucan

Q&A with Kimmo Lucas, President & CEO of Cevena Bioproducts Inc.

NBJ: What were the biggest challenges facing your business segment in 2005?

KL: One of the biggest challenges was lack of clinical substantiation for claims, which contributes to the credibility problem we face as an industry. Manufacturers need to invest in science that proves the effectiveness of our products, then market to consumers. This will obviously build credibility.

NBJ: Briefly describe a couple of recent company highlights.

All access premium subscription

This content requires a subscription to Nutrition Business Journal.

As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.

Email [email protected] for more information about subscribing.